Sharon Benzeno - Net Worth and Insider Trading
Sharon Benzeno Net Worth
The estimated net worth of Sharon Benzeno is at least $2 Million dollars as of 2024-08-27. Sharon Benzeno is the Chief Commercial Ofc Imm Med of Adaptive Biotechnologies Corp and owns about 327,415 shares of Adaptive Biotechnologies Corp (ADPT) stock worth over $2 Million. Details can be seen in Sharon Benzeno's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sharon Benzeno has not made any transactions after 2024-03-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sharon Benzeno
Sharon Benzeno Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sharon Benzeno owns 1 companies in total, including Adaptive Biotechnologies Corp (ADPT) .
Click here to see the complete history of Sharon Benzeno’s form 4 insider trades.
Insider Ownership Summary of Sharon Benzeno
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ADPT | Adaptive Biotechnologies Corp | 2024-03-05 | Chief Commercial Ofc Imm Med |
Sharon Benzeno Latest Holdings Summary
Sharon Benzeno currently owns a total of 1 stock. Sharon Benzeno owns 327,415 shares of Adaptive Biotechnologies Corp (ADPT) as of March 5, 2024, with a value of $2 Million.
Latest Holdings of Sharon Benzeno
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ADPT | Adaptive Biotechnologies Corp | 2024-03-05 | 327,415 | 4.81 | 1,574,866 |
Holding Weightings of Sharon Benzeno
Sharon Benzeno Form 4 Trading Tracker
According to the SEC Form 4 filings, Sharon Benzeno has made a total of 28 transactions in Adaptive Biotechnologies Corp (ADPT) over the past 5 years, including 0 buys and 28 sells. The most-recent trade in Adaptive Biotechnologies Corp is the sale of 29,390 shares on March 5, 2024, which brought Sharon Benzeno around $101,102.
Insider Trading History of Sharon Benzeno
- 1
Sharon Benzeno Trading Performance
Sharon Benzeno Ownership Network
Ownership Network List of Sharon Benzeno
Ownership Network Relation of Sharon Benzeno
Sharon Benzeno Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Sharon Benzeno is the Chief Commercial Ofc Imm Med of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include SVP and General Counsel Stacy L Taylor , Chief Financial Officer Tycho Peterson , and Principal Accounting Officer Kyle Piskel .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Sharon Benzeno made 2 insider transaction in Adaptive Biotechnologies Corp (ADPT) with a net sale of 41,139. Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 258,417 shares made by Tycho Peterson , a net sale of 59,181 shares made by Stacy L Taylor , and a net sale of 11,515 shares made by Kyle Piskel .
In summary, during the past 3 months, insiders sold 26,922 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 26,922 shares. During the past 18 months, 576,996 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 576,996 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
Sharon Benzeno Mailing Address
Above is the net worth, insider trading, and ownership report for Sharon Benzeno. You might contact Sharon Benzeno via mailing address: C/o Adaptive Biotechnologies Corporation, 1551 Eastlake Ave E Ste 200, Seattle Wa 98102.